Jamie Christensen, EVP, Chief Scientific Officer at Mirati Therapeutics, Inc. (MRTX), sold 3,603 shares at $42.38 ($153K) on 2023-01-17, disclosed to the SEC on 2023-01-19.
Seasonal sale ($153k) by EVP, Chief Scientific Officer — this insider has traded MRTX in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.38 | 887 | $38K | 24.6% |
| 2 | $42.38 | 1,358 | $58K | 37.7% |
| 3 | $42.38 | 1,358 | $58K | 37.7% |
| Total | $42.38 avg | 3,603 | $153K | 100% |
| Filing → |
| MRTX | SELL | 2023-12-19 | $275K | — | Filing → |
| MRTX | SELL | 2023-09-12 | $170K | — | Filing → |
| MRTX | SELL | 2023-05-24 | $28K | — | Filing → |